Evidence map›Paper›PMID 26464331›Full record

ArticleCardiovascular research2015

Knockout of p21-activated kinase-1 attenuates exercise-induced cardiac remodelling through altered calcineurin signalling.

Robert T Davis, Jillian N Simon, Megan Utter, Paul Mungai, Manuel G Alvarez, Shamim A K Chowdhury, Ahlke Heydemann, Yunbo Ke, Beata M Wolska, R John Solaro

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Robert T DavisDepartment of Physiology and Biophysics, Center for Cardiovascular Research, University of Illinois at Chicago, 835 S. Wolcott Ave-Rm. E202, Chicago, IL 60612, USA.
Jillian N SimonDepartment of Physiology and Biophysics, Center for Cardiovascular Research, University of Illinois at Chicago, 835 S. Wolcott Ave-Rm. E202, Chicago, IL 60612, USA.
Megan UtterDepartment of Physiology and Biophysics, Center for Cardiovascular Research, University of Illinois at Chicago, 835 S. Wolcott Ave-Rm. E202, Chicago, IL 60612, USA.
Paul MungaiDepartment of Physiology and Biophysics, Center for Cardiovascular Research, University of Illinois at Chicago, 835 S. Wolcott Ave-Rm. E202, Chicago, IL 60612, USA.
Manuel G AlvarezDepartment of Physiology and Biophysics, Center for Cardiovascular Research, University of Illinois at Chicago, 835 S. Wolcott Ave-Rm. E202, Chicago, IL 60612, USA.
Shamim A K ChowdhuryDepartment of Physiology and Biophysics, Center for Cardiovascular Research, University of Illinois at Chicago, 835 S. Wolcott Ave-Rm. E202, Chicago, IL 60612, USA.
Ahlke HeydemannDepartment of Physiology and Biophysics, Center for Cardiovascular Research, University of Illinois at Chicago, 835 S. Wolcott Ave-Rm. E202, Chicago, IL 60612, USA.
Yunbo KeDepartment of Physiology and Biophysics, Center for Cardiovascular Research, University of Illinois at Chicago, 835 S. Wolcott Ave-Rm. E202, Chicago, IL 60612, USA.
Beata M WolskaDepartment of Physiology and Biophysics, Center for Cardiovascular Research, University of Illinois at Chicago, 835 S. Wolcott Ave-Rm. E202, Chicago, IL 60612, USA Department of Medicine, Section of Cardiology, Center for Cardiovascular Research, University of Illinois, Chicago, IL 60612, USA.
R John SolaroDepartment of Physiology and Biophysics, Center for Cardiovascular Research, University of Illinois at Chicago, 835 S. Wolcott Ave-Rm. E202, Chicago, IL 60612, USA solarorj@uic.edu.
University of Illinois Chicago · US

Funding

Sarcomeric Modifications and Progressive Cardiac MaladaptationP01HL062426 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DE TOMBE, PIETER P. · 2000 to 2020
$42.4M
TRAINING IN CELLULAR SIGNALLING IN THE CARDIOVASCULAR SYT32HL007692 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SOLARO, R JOHN · 1990 to 2014
$8.5M
Troponin Mudulation in Heart FailureR01HL064035 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SOLARO, R JOHN, WOLSKA, BEATA M. · 2000 to 2013
$4.7M
Myofilament signaling and cardiac disordersR01HL128468 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SOLARO, R JOHN, WOLSKA, BEATA M. · 2016 to 2019
$1.6M
Medical Research Council G10002647NHLBI NIH HHS P01 HL062426NHLBI NIH HHS P01HL062426NHLBI NIH HHS R01 HL064035NHLBI NIH HHS R01 HL128468NHLBI NIH HHS T32HL07692
6 · The paper itself

Abstract

aimsDespite its known cardiovascular benefits, the intracellular signalling mechanisms underlying physiological cardiac growth remain poorly understood. Therefore, the purpose of this study was to investigate a novel role of p21-activated kinase-1 (Pak1) in the regulation of exercise-induced cardiac hypertrophy. METHODS AND

resultsWild-type (WT) and Pak1 KO mice were subjected to 6 weeks of treadmill endurance exercise training (ex-training). Cardiac function was assessed via echocardiography, in situ haemodynamics, and the pCa-force relations in skinned fibre preparations at baseline and at the end of the training regimen. Post-translational modifications to the sarcomeric proteins and expression levels of calcium-regulating proteins were also assessed following ex-training. Heart weight/tibia length and echocardiography data revealed that there was marked hypertrophy following ex-training in the WT mice, which was not evident in the KO mice. Additionally, following ex-training, WT mice demonstrated an increase in cardiac contractility, myofilament calcium sensitivity, and phosphorylation of cardiac myosin-binding protein C, cardiac TnT, and tropomyosin compared with KO mice. With ex-training in WT mice, there were also increased protein levels of calcineurin and increased phosphorylation of phospholamban.

conclusionsOur data suggest that Pak1 is essential for adaptive physiological cardiac remodelling and support previous evidence that demonstrates Pak1 signalling is important for cardiac growth and survival.

Indexed as

Cardiomegaly, Exercise-InducedGene Knockout TechniquesPhysical ExertionVentricular RemodelingAdaptation, PhysiologicalAnimalsCalcineurinCalcium-Binding ProteinsCardiomegalyCarrier ProteinsExercise ToleranceGenotypeHemodynamicsMice, KnockoutMyocardial ContractionMyocardiumCalcineurinCalcium-Binding ProteinsCarrier ProteinsMyosin Binding Protein Cp21-Activated KinasesPak1 protein, mousePhospholambanTropomyosinTroponin TCardiac functionExercisePhysiological hypertrophyTreadmill running

Identifiers

PMID26464331
PMCPMC4648200
OpenAlexW2168466966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.